Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002052 · ClinicalTrials.gov registry record · NA
Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
NCT00002052 is a NA study that has completed, run by University of Southern California.
The verdict
NCT00002052, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To compare the effectiveness of standard treatment with parenteral ampicillin and oral amoxicillin compared to initial daily therapy with ceftriaxone followed by 3 times weekly suppressive treatment for salmonella infections in AIDS patients.
Interventions
- DRUG Amoxicillin trihydrate
- DRUG Ceftriaxone sodium
- DRUG Ampicillin sodium
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002052
The ClinicalTrials.gov registry entry for NCT00002052 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Amoxicillin trihydrate is the first listed.
NCT00002052 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002052 about?
NCT00002052 is a clinical study titled "Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients". To compare the effectiveness of standard treatment with parenteral ampicillin and oral amoxicillin compared to initial daily therapy with ceftriaxone followed by 3 times weekly suppressive treatment for salmonella infections in AIDS patients.
What is the current status of trial NCT00002052?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002052?
The interventions under investigation include: Amoxicillin trihydrate (DRUG), Ceftriaxone sodium (DRUG), Ampicillin sodium (DRUG).
Who is sponsoring clinical trial NCT00002052?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.